Seastar Medical Holding Corp. 8-K Summary
Business Context and Reporting Period
Seastar Medical Holding Corp. (Nasdaq: ICU) filed this Current Report on Form 8-K on March 30, 2023. The filing serves to announce the Company's financial condition and results of operations for the fiscal year ended December 31, 2022. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This 8-K filing references a press release (Exhibit 99.1) containing the detailed financial results but does not explicitly state specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the text of this report. The filing text does not provide a clear value for these metrics.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the issuance of a press release regarding the full-year 2022 results.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, or a discussion of risks and contingencies within the body of the 8-K. The information is deemed "furnished" rather than "filed" and is not incorporated by reference into other Exchange Act filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 30, 2023) for specific revenue, net income, and cash flow figures for the year ended December 31, 2022.
- Verify the Company's liquidity position and debt obligations as detailed in the referenced press release.
- Check for any updated forward-looking statements or guidance provided in the press release not included in this 8-K summary.
- Confirm the trading status of Common Stock (ICU) and Warrants (ICUCW) on The Nasdaq Stock Market LLC.